Genetic and transcriptional evolution alters cancer cell line drug response

Uri Ben‐David(Broad Institute), Benjamin A. Siranosian(Broad Institute), Gavin Ha(Broad Institute), Helen Tang(Broad Institute), Yaara Oren(Broad Institute), Kunihiko Hinohara(Dana-Farber Cancer Institute), Craig A. Strathdee(Broad Institute), Joshua M. Dempster(Broad Institute), Nicholas Lyons(Broad Institute), Robert Burns(Dana-Farber Cancer Institute), Anwesha Nag(Dana-Farber Cancer Institute), Guillaume Kugener(Broad Institute), Beth A. Cimini(Broad Institute), Peter Tsvetkov(Broad Institute), Yosef E. Maruvka(Broad Institute), Ryan O’Rourke(Broad Institute), Anthony J. Garrity(Broad Institute), Andrew A. Tubelli(Broad Institute), Pratiti Bandopadhayay(Harvard University), Aviad Tsherniak(Broad Institute), Francisca Vázquez(Broad Institute), Bang Wong(Broad Institute), Chet Birger(Broad Institute), Mahmoud Ghandi(Broad Institute), Aaron R. Thorner(Dana-Farber Cancer Institute), Joshua A. Bittker(Broad Institute), Matthew Meyerson(Harvard University), Gad Getz(Broad Institute), Rameen Beroukhim(Dana-Farber Cancer Institute), Todd R. Golub(Broad Institute)
Nature
August 1, 2018
10.1038/s41586-018-0409-3
Cited by 938Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis